PLUN logo

ProstaLund AB (publ) Stock Price

OM:PLUN Community·SEK 6.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PLUN Share Price Performance

SEK 0.21
-0.69 (-76.35%)
SEK 0.21
-0.69 (-76.35%)
Price SEK 0.21

PLUN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with mediocre balance sheet.

6 Risks
0 Rewards

ProstaLund AB (publ) Key Details

SEK 12.0m

Revenue

SEK 3.8m

Cost of Revenue

SEK 8.2m

Gross Profit

SEK 28.6m

Other Expenses

-SEK 20.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.65
68.12%
-169.27%
6.8%
View Full Analysis

About PLUN

Founded
1991
Employees
6
CEO
Malin Melander
WebsiteView website
prostalund.se

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow, a temporary prostate stent; Oruflow, a urine flow meter; and Schelin Catheter, a medical device intended for intraprostatic and periprostatic injection of legally market drugs. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.

Recent PLUN News & Updates

Recent updates

No updates